What medicine does esophagus cancer turn bone cancer to take

Update Date: Source: Network

summary

My father-in-law got esophageal cancer last year, but it's OK to reexamine the focus after radiotherapy. The doctor has been much better after treatment. I'd like to share with you my experience on what medicine to take for esophageal cancer to bone cancer

What medicine does esophagus cancer turn bone cancer to take

Drug 1: epidermal growth factor receptor targeted therapy: epidermal growth factor receptor belongs to type I transmembrane tyrosine kinase growth factor receptor, which is the expression product of proto oncogene c-erbB-1 and can regulate cell growth, differentiation, angiogenesis and apoptosis. Its signaling pathway is closely related to the growth, invasion and metastasis of malignant tumors. EGFR overexpression is found in most epithelial tumors, and 40% - 80% of esophageal cancer patients are accompanied by EGFR overexpression.

Drug 2: tumor angiogenesis inhibitor: vascular endothelial growth factor (VEGF) and its receptor (VEGFR-1) play an important role in inducing angiogenesis. Anti angiogenesis therapy may become another potential therapeutic target for esophageal cancer.

Drug 3: cell cycle inhibitors cyclin dependent kinase inhibitors: cell cycle inhibitors cyclin dependent kinases (CDKs) are a family of proteins that regulate cell cycle. In tumor tissues, CDKs "over activation" leads to uncontrolled cell proliferation.

matters needing attention

Objective to find out the population or individual with genetic susceptibility to esophageal cancer and focus on prevention. The families with two or more cases of esophageal cancer death in three generations were regarded as high-risk families, and the family members aged from 40 to 69 were regarded as high-risk population. Preliminary screening, multiple tests and prospective observation were carried out to find out the genetic susceptibility individuals. Persuade him to change his unhealthy and harmful habits and provide vitamins and preventive drugs. This strategy can reduce the number of key prevention personnel and has strong pertinence. It can save a lot of manpower and material resources and is easy to be accepted by the masses.